Form 4 for BSX Boston Scientific
Accepted 2024-09-06 00:00:00 ET · period of report 2024-09-05 · accession 0001225208-24-008529 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-06 | 2024-09-05 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $16.79 | +111.9K | 1.73M | +7% | +$1.88M |
| D | 2024-09-06 | 2024-09-05 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $81.17 | -162.8K | 1.62M | -9% | -$13.21M |
| DM | 2024-09-06 | 2024-09-05 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -111.9K | 281.1K | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-05 | M | A | 55,675 | $16.31 | 1,785,764 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-05 | M | A | 56,211 | $17.26 | 1,730,089 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-05 | S | D | 162,777 | $81.17 | 1,622,987 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $80.52 to $81.80, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-09-05 | M | D | 55,675 | $0.00 | 111,351 | D | $16.31 · — to 2025-02-23 | 55,675 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-09-05 | M | D | 56,211 | $0.00 | 281,057 | D | $17.26 · — to 2026-02-22 | 56,211 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |